We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEXI
1251
DELISTED
NexImmune, Inc. Common Stock
NEXI
$81K ﹤0.01%
2,000
– –
IRON icon
1252
Disc Medicine
IRON
$2.97B
$80K ﹤0.01%
1,583
-2,334
-60% -$103K
PHAS
1253
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$76K ﹤0.01%
126,600
-160,000
-56% -$153K
IGC icon
1254
IGC Pharma
IGC
$26.1M
$74K ﹤0.01%
139,000
– –
TLPH icon
1255
Talphera
TLPH
$74.2M
$74K ﹤0.01%
15,165
– –
NAVB
1256
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$74K ﹤0.01%
102,440
– –
NSPR icon
1257
InspireMD
NSPR
$33.8M
$73K ﹤0.01%
36,667
– –
PRHI
1258
Presurance Holdings
PRHI
$18.2M
$72K ﹤0.01%
6,143
– –
ALGS icon
1259
Aligos Therapeutics
ALGS
$34.1M
$69K ﹤0.01%
+2,280
New +$77.4K
ARTW icon
1260
Arts-Way Manufacturing Co
ARTW
$11.1M
$69K ﹤0.01%
23,286
-6,714
-22% -$20.1K
LSF icon
1261
Laird Superfood
LSF
$50M
$69K ﹤0.01%
36,000
– –
ASPU
1262
DELISTED
ASPEN GROUP, INC.
ASPU
$69K ﹤0.01%
69,900
– –
MSN icon
1263
Emerson Radio
MSN
$7.71M
$68K ﹤0.01%
102,100
– –
ELOX
1264
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$67K ﹤0.01%
6,235
-1,500
-19% -$20.7K
PLAG icon
1265
Planet Green Holdings
PLAG
$8.36M
$66K ﹤0.01%
8,300
– –
PZG icon
1266
Paramount Gold Nevada
PZG
$119M
$66K ﹤0.01%
150,000
– –
QNGY
1267
DELISTED
Quanergy Systems, Inc.
QNGY
$66K ﹤0.01%
+8,000
New +$180K
PFIN
1268
DELISTED
P&F Industries
PFIN
$66K ﹤0.01%
11,688
– –
MGLD icon
1269
Marygold Companies
MGLD
$47.8M
$64K ﹤0.01%
+46,000
New +$62.3K
AIRI icon
1270
Air Industries Group
AIRI
$12.7M
$63K ﹤0.01%
9,000
-1,000
-10% -$7.36K
CYCN icon
1271
Cyclerion Therapeutics
CYCN
$16.7M
$63K ﹤0.01%
5,750
– –
CLYM
1272
Climb Bio
CLYM
$802M
$62K ﹤0.01%
20,423
+2,023
+11% +$9.57K
IMA
1273
ImageneBio Inc
IMA
$64M
$58K ﹤0.01%
+1,083
New +$59.7K
CATX icon
1274
Perspective Therapeutics
CATX
$339M
$57K ﹤0.01%
18,400
– –
APLT
1275
DELISTED
Applied Therapeutics
APLT
$56K ﹤0.01%
58,800
-50,000
-46% -$81.9K
49 50
51
52 53

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.